Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary L Lopresti

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
New Approaches to Improving Survival After Neoadjuvant Chemotherapy: The Role of Intraperitoneal Therapy and Heated Intraperitoneal Chemotherapy in Ovarian CancerMary L Lopresti, Christina A Bandera, Thomas J Miner
Technology in Cancer Research & Treatment|October 26, 2021
How Does Invasive Breast Cancer Oncotype Dx Recurrence Score on Core Needle Biopsies Influence Neoadjuvant Treatment Decision? A Descriptive StudyGahie Nam, Kamaljeet Singh, Mary L Lopresti, et al.
Clinical Breast Cancer|September 12, 2017
Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast CancerYihong Wang, Alexander S Brodsky, Jinjun Xiong, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 22, 2019
Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practiceOlga Yankulina, Andrew R Zullo, Sarah E Cabral, et al.
Annals of Surgical Oncology|July 26, 2019
Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary ClinicChelsey C Ciambella, Charu Taneja, Don S Dizon, et al.
British Journal of Haematology|March 13, 2019
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapyAdam J Olszewski, Anna D Chorzalska, Annette S Kim, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
New Approaches to Improving Survival After Neoadjuvant Chemotherapy: The Role of Intraperitoneal Therapy and Heated Intraperitoneal Chemotherapy in Ovarian CancerMary L Lopresti, Christina A Bandera, Thomas J Miner
Technology in Cancer Research & Treatment|October 26, 2021
How Does Invasive Breast Cancer Oncotype Dx Recurrence Score on Core Needle Biopsies Influence Neoadjuvant Treatment Decision? A Descriptive StudyGahie Nam, Kamaljeet Singh, Mary L Lopresti, et al.
Clinical Breast Cancer|September 12, 2017
Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast CancerYihong Wang, Alexander S Brodsky, Jinjun Xiong, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 22, 2019
Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practiceOlga Yankulina, Andrew R Zullo, Sarah E Cabral, et al.
Annals of Surgical Oncology|July 26, 2019
Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary ClinicChelsey C Ciambella, Charu Taneja, Don S Dizon, et al.
British Journal of Haematology|March 13, 2019
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapyAdam J Olszewski, Anna D Chorzalska, Annette S Kim, et al.
Pageof 1